China Tobacco Hong Kong 2025 Interim Results: Revenue HKD 10.3 billion, up 18.5% year-on-year; New Tobacco Export Business Revenue HKD 14.6 million, down 66.5% year-on-year

Aug.22.2025
China Tobacco Hong Kong 2025 Interim Results: Revenue HKD 10.3 billion, up 18.5% year-on-year; New Tobacco Export Business Revenue HKD 14.6 million, down 66.5% year-on-year
China Tobacco International (Hong Kong) recorded revenue of HKD 10.32 billion in the first half of 2025, up 18.5% year-on-year, with gross profit down 1.8%. Net profit attributable to shareholders was HKD 706 million, up 9.8% year-on-year. Revenue from the new tobacco export business was HKD 14.6 million, down 66.5% year-on-year.

On the evening of August 22, Beijing time, China Tobacco International (Hong Kong) Company Limited (6055.HK) released its interim results for the period ended June 30, 2025.

Key Data:

 

  • Revenue: HKD 10.32 billion, up 18.5% year-on-year
  • Gross profit: HKD 946 million, down 1.8% year-on-year
  • Net profit attributable to shareholders: HKD 706 million, up 9.8% year-on-year
  • Earnings per share: HKD 1.02 (2024 H1: HKD 0.93)
  • Interim dividend: HKD 0.19 per share, up 26.7% year-on-year

 

Performance by Business Segment

 

  • Tobacco leaf import business: Revenue HKD 8.399 billion, up 23.5% year-on-year; however, gross profit margin declined, gross profit decreased by 7.7%.
  • Tobacco leaf export business: Revenue HKD 1.156 billion, up 25.9% year-on-year; gross profit increased by 124.1%, becoming the main driver of profit growth.
  • Cigarette export business: Sales volume decreased by 7.9%, but with structural optimization and expansion of self-operated channels, revenue remained basically flat (+0.8%), and gross profit increased by 16.8%.
  • New tobacco export business: Affected by geopolitical and regulatory factors, revenue was HKD 14.6 million, down 66.5% year-on-year.
China Tobacco Hong Kong 2025 Interim Results: Revenue HKD 10.3 billion, up 18.5% year-on-year; New Tobacco Export Business Revenue HKD 14.6 million, down 66.5% year-on-year
China Tobacco International (HK) Mid-term Financial Report screenshot for 2025 | Source: China Tobacco International (HK) Financial Report

 

Finance and Outlook

 

  • Financing cost: Down 28.2% to HKD 82.9 million, easing profit pressure.
  • Cash and deposits: HKD 3.98 billion, significantly increased compared with the end of 2024.
  • Outlook for the second half: The company emphasized that it will continue to strengthen the resilience of the tobacco leaf supply chain, expand duty-free cigarette channels, and promote innovation and market access for new tobacco products, in order to cope with international regulatory and geopolitical risks.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Capital Group Takes 5.61% Stake in KT&G, Joining Major Foreign Shareholders
Capital Group Takes 5.61% Stake in KT&G, Joining Major Foreign Shareholders
KT&G disclosed in a regulatory filing on Friday that Capital Research and Management Company, the investment management arm of Capital Group, had acquired a 5.61% stake through purchases made on April 22 and May 4. The move places Capital Group among KT&G’s prominent foreign shareholders, alongside BlackRock, First Eagle Investment Management and Singapore’s sovereign wealth fund GIC.
May.08 by 2FIRSTS.ai
France Vape Market 2026: Use Reaches 7.9% Amid Tax, Regulatory and Scientific Debate
France Vape Market 2026: Use Reaches 7.9% Amid Tax, Regulatory and Scientific Debate
France remains one of Europe’s active vape markets in 2026, with adult vaping prevalence rising to 7.9%; at the same time, e-liquid taxation, public-space restrictions, advertising compliance and health-risk debate are pushing the industry into a critical policy period.
Jun.23
WHO’s First Global Report on Nicotine Pouches: Harm Reduction Questions Remain Amid Global Regulatory Warning
WHO’s First Global Report on Nicotine Pouches: Harm Reduction Questions Remain Amid Global Regulatory Warning
Ahead of World No Tobacco Day 2026, WHO released its first global report on nicotine pouches, warning that rapid market growth, youth-oriented marketing and weak regulation are converging. 2Firsts views the report as an important warning, but not a complete risk assessment, with harm-reduction questions still unresolved.
Special Report
May.17
FDA Tobacco Center Plans Faster Review Process for Certain Supplemental PMTAs
FDA Tobacco Center Plans Faster Review Process for Certain Supplemental PMTAs
FDA Center for Tobacco Products Acting Director Bret Koplow issued a statement on May 7 outlining new steps to accelerate tobacco product premarket application review. The statement said CTP reduced the backlog of applications by approximately 70% in 2025 and that there is no longer a queue for PMTAs pending acceptance review.
May.09 by 2FIRSTS.ai
FDA Tobacco Center Pushes Review-Efficiency Statement After Commissioner’s Exit
FDA Tobacco Center Pushes Review-Efficiency Statement After Commissioner’s Exit
FDA CTP issued a May 7 statement on accelerating product review and improving PMTA efficiency, but did not push it via official X and newsletter until May 13, one day after FDA Commissioner Marty Makary’s resignation was confirmed. FDA has not explained the delay, and no public evidence links it directly to the leadership change. The timing is notable given CTP’s usual 24-hour distribution practice.
Special Report
May.14
Data|China’s January-May Vape Exports: U.S. Shipments Fall 13.8% as Japan Posts Fastest Growth
Data|China’s January-May Vape Exports: U.S. Shipments Fall 13.8% as Japan Posts Fastest Growth
According to China Customs export data analyzed by 2Firsts, the United States remained China’s largest destination for vape-related exports during January-May 2026 despite a 13.82% year-on-year decline in export value. Meanwhile, exports to Japan, Russia, Indonesia and the United Arab Emirates recorded strong growth, highlighting continued diversification across China’s export markets.
Special Report
Jun.29